Ovid Therapeutics Statistics
Total Valuation
OVID has a market cap or net worth of $54.87 million. The enterprise value is $8.38 million.
| Market Cap | 54.87M |
| Enterprise Value | 8.38M |
Important Dates
The next estimated earnings date is Friday, August 2, 2024, before market open.
| Earnings Date | Aug 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OVID has 70.94 million shares outstanding. The number of shares has increased by 0.32% in one year.
| Shares Outstanding | 70.94M |
| Shares Change (YoY) | +0.32% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 15.87% |
| Owned by Institutions (%) | 62.44% |
| Float | 40.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 115.87 |
| Forward PS | 157.90 |
| PB Ratio | 0.70 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.47, with a Debt / Equity ratio of 0.58.
| Current Ratio | 10.47 |
| Quick Ratio | n/a |
| Debt / Equity | 0.58 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.60% and return on invested capital (ROIC) is -49.85%.
| Return on Equity (ROE) | -53.60% |
| Return on Assets (ROA) | -37.80% |
| Return on Capital (ROIC) | -49.85% |
| Revenue Per Employee | $11,838 |
| Profits Per Employee | -$1.27M |
| Employee Count | 40 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.25% in the last 52 weeks. The beta is 0.58, so OVID's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -77.25% |
| 50-Day Moving Average | 2.59 |
| 200-Day Moving Average | 3.19 |
| Relative Strength Index (RSI) | 22.32 |
| Average Volume (20 Days) | 2,324,892 |
Short Selling Information
The latest short interest is 2.86 million, so 4.04% of the outstanding shares have been sold short.
| Short Interest | 2.86M |
| Short Previous Month | 2.87M |
| Short % of Shares Out | 4.04% |
| Short % of Float | 7.02% |
| Short Ratio (days to cover) | 24.61 |
Income Statement
In the last 12 months, OVID had revenue of $473,535 and -$50.68 million in losses. Loss per share was -$0.73.
| Revenue | 473,535 |
| Gross Profit | 473,535 |
| Operating Income | -61.81M |
| Pretax Income | -50.68M |
| Net Income | -50.68M |
| EBITDA | -49.08M |
| EBIT | -50.68M |
| Loss Per Share | -$0.73 |
Balance Sheet
The company has $92.19 million in cash and $45.70 million in debt, giving a net cash position of $46.49 million or $0.66 per share.
| Cash & Cash Equivalents | 92.19M |
| Total Debt | 45.70M |
| Net Cash | 46.49M |
| Net Cash Per Share | $0.66 |
| Equity (Book Value) | 78.28M |
| Book Value Per Share | 1.10 |
| Working Capital | 84.27M |
Cash Flow
In the last 12 months, operating cash flow was -$50.35 million and capital expenditures -$45,748, giving a free cash flow of -$50.40 million.
| Operating Cash Flow | -50.35M |
| Capital Expenditures | -45,748 |
| Free Cash Flow | -50.40M |
| FCF Per Share | -$0.71 |
Margins
Gross margin is 100.00%, with operating and profit margins of -13,052.08% and -10,701.80%.
| Gross Margin | 100.00% |
| Operating Margin | -13,052.08% |
| Pretax Margin | -10,701.80% |
| Profit Margin | -10,701.80% |
| EBITDA Margin | -10,363.78% |
| EBIT Margin | -10,701.80% |
| FCF Margin | -10,643.44% |
Dividends & Yields
OVID does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.32% |
| Shareholder Yield | -0.32% |
| Earnings Yield | -92.36% |
| FCF Yield | -91.86% |
Analyst Forecast
The average price target for OVID is $4.04, which is 422.37% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.04 |
| Price Target Difference | 422.37% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 183.67% |
| EPS Growth Forecast (5Y) | -10.79% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OVID has an Altman Z-Score of -2.96 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.96 |
| Piotroski F-Score | 2 |